Stock listing

EIKN Stock Price, News, Filings & Events — Eikon Therapeutics, Inc.

Selected listing: EIKN · BOATS · USD · US

This page tracks Eikon Therapeutics, Inc.'s EIKN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EIKN:BOATS. EIKN:BOATS is the stock-level entry point for investors researching Eikon Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Eikon Therapeutics, Inc. is a public company traded under the ticker EIKN in the American market. The company has a market capitalization of approximately $481.8 million. Eikon focuses on developing innovative therapeutic solutions, leveraging advanced technologies to address unmet medical needs.

EIKN:BOATSUSDUSUpdated September 12, 2026
Eikon Therapeutics, Inc. logo
Ticker
EIKN:BOATS
Asset type
Stock
Market cap
$484.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Eikon Therapeutics, Inc. EIKN:BOATS stock context

This page tracks Eikon Therapeutics, Inc.'s EIKN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EIKN:BOATS. EIKN:BOATS is the stock-level entry point for investors researching Eikon Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Eikon Therapeutics, Inc. is a public company traded under the ticker EIKN in the American market. The company has a market capitalization of approximately $481.8 million. Eikon focuses on developing innovative therapeutic solutions, leveraging advanced technologies to address unmet medical needs.

Latest news from Eikon Therapeutics, Inc.

All Eikon Therapeutics, Inc. news →

Research Eikon Therapeutics, Inc.

Alternate listings